Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy.
Fleurence J, Fougeray S, Bahri M, Cochonneau D, Clémenceau B, Paris F, Heczey A, Birklé S.
Fleurence J, et al. Among authors: fougeray s.
J Immunol Res. 2017;2017:5604891. doi: 10.1155/2017/5604891. Epub 2017 Jan 5.
J Immunol Res. 2017.
PMID: 28154831
Free PMC article.
Review.